Dr. Eric J. Feldman, MD

Dr. Feldman practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Feldman's NPI, 1972690055, was assigned on October 9, 2006. Dr. Feldman graduated from New York Medical College in 1981. Dr. Feldman's New York license number on file is 153850.

Dr. Feldman's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Feldman's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Feldman to 1 more school health center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Feldman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Feldman's licenses on file in 2 states: New York and Texas.

Dmand AI lists colorectal cancer and neutropenia among the conditions Dr. Feldman treats.

CMS data shows 47 Medicare services from Dr. Feldman across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $4,940 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Feldman in 2024. The largest group is 75 to 84, with 11 patients. 70% of them have high blood pressure, and 63% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 67, with 31% women.

In 2024, Dr. Feldman wrote 140 Medicare Part D claims for 13 patients. 68% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $391 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Feldman for performance year 2024, reported as part of a group.

Dmand AI links 149 papers to Dr. Feldman, published from 2002 to 2025. 2013 was the busiest year, with 8. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Cytarabine. Dr. Feldman has published most often in Leukemia. Dr. Feldman's most frequent co-authors are Tauseef F. Ahmed, MD, Gail J. Roboz, MD and Ellen Kelly Ritchie, MD.

Dmand AI links Dr. Feldman to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Leukemia, Myeloid, Acute, Hematologic Neoplasms and Multiple Myeloma. Weill Medical College of Cornell University sponsors the most, 3.

CMS Open Payments shows 14 general payments to Dr. Feldman from 9 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 87% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,375.

Dmand AI lists 2 awards for Dr. Feldman, most recently CMS Stage 1 EHR in 2013.

Dr. Feldman graduated from New York Medical College in 1981. Dr. Feldman is a member of ASCO and ASH.

Dr. Feldman is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.